COVID-19: Health Canada’s chief medical advisor outlines use of Pfizer antiviral pill
Health Canada’s Chief Medical Advisor Dr. Surpiya Sharma explained in a press conference on Monday how the newly-approved Pfizer antiviral pill for COVID-19 works. The drug is intended for use as soon as possible after the diagnosis of COVID-19 in a patient and within five days of the start of symptoms.
UP NEXT
NOW PLAYING: other
COVID-19: Health Canada’s chief medical advisor outlines use of Pfizer antiviral pill
Global News
UP NEXT
-
Flooding damages bridges in Mafeking
Global News
-
Prince Charles and Camilla kick off Canadian tour focused on Indigenous issues
-
Health Canada approves first Quebec patient for magic mushroom therapy
-
Decision Ontario: Doug Ford's lead remains firm after leaders debate
-
Hundreds of Ukrainian troops in Azovstal steel mill surrender to Russian forces
-
‘White supremacy is a poison': Biden condemns racism, gun violence during Buffalo visit
-
Quebec Premier defends Bill 96, says access to health care won’t change for Anglos
-
Toronto Maple Leafs superstar Mitch Marner the victim of an armed carjacking
-
Prince Charles commits to ‘listening’ to Indigenous peoples as Canadian royal tour begins
-
Prince Charles and Camilla set to arrive in Canada today
-
U.S president Joe Biden and First Lady Jill Biden set to visit Buffalo
-
Recap and reaction of Ontario Provincial Election debate
-
Buffalo security guard killed in mass shooting hailed as hero
-
Canada's visa processing system faces controversy over delays, outsourced work
-
Ukraine says troops in Kharkiv region are pushing back Russian forces
-
Canadian racism, homegrown extremism also in focus after Buffalo mass shooting
